{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:45:08Z","timestamp":1780713908889,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.amjopharm.2007.05.004","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T11:16:05Z","timestamp":1187867765000},"page":"100-111","source":"Crossref","is-referenced-by-count":21,"title":["Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a medicare managed care population"],"prefix":"10.1016","volume":"5","author":[{"given":"Monali J.","family":"Bhosle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian T.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger T.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Balkrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2007.05.004_bib1","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(99)04240-3","article-title":"Glaucoma","volume":"354","author":"Coleman","year":"1999","journal-title":"Lancet."},{"key":"10.1016\/j.amjopharm.2007.05.004_bib2","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199111143252004","article-title":"Racial differences in the cause-specific prevalence of blindness in east Baltimore","volume":"325","author":"Sommer","year":"1991","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2007.05.004_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0161-6420(01)01008-9","article-title":"Causes of blindness and visual impairment in a population-based sample of US Hispanics","volume":"109","author":"Rodriguez","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib4","first-page":"83","article-title":"Models of open-angle glaucoma prevalence and incidence in the United States","volume":"38","author":"Quigley","year":"1997","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.amjopharm.2007.05.004_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/pgmj.74.878.709","article-title":"Glaucoma: Diagnosis and management","volume":"74","author":"Infeld","year":"1998","journal-title":"Postgrad Med J."},{"key":"10.1016\/j.amjopharm.2007.05.004_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archopht.117.5.573","article-title":"The Ocular Hypertension Treatment Study: Design and baseline description of the participants","volume":"117","author":"Gordon","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archopht.122.4.532","article-title":"Prevalence of open-angle glaucoma among adults in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200522010-00001","article-title":"Management of glaucoma: Focus on pharmacological therapy","volume":"22","author":"Marquis","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/ajhp\/55.3.272","article-title":"Costs of glaucoma medications","volume":"55","author":"Fiscella","year":"1998","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1385\/AO:37:1:033","article-title":"Latanoprost vs combined therapy with timolol plus dorzolamide in open-angle glaucoma: A 24-month study","volume":"37","author":"Polo","year":"2005","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib11","series-title":"Xalatan [package insert]","year":"2000"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib12","series-title":"Lumigan [package insert]","year":"2001"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib13","series-title":"Travatan [package insert]","year":"2001"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib14","series-title":"Xalatan [package insert]","year":"2003"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib15","series-title":"Xalatan marks 10th anniversary. Prostaglandin glaucoma medication overcame obstacles","year":"2006"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005650-200209000-00009","article-title":"Patient adherence and medical treatment outcomes: A meta-analysis","volume":"40","author":"DiMatteo","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000011","article-title":"Interventions for helping patients to follow prescriptions for medications","volume":"2","author":"Haynes","year":"2002","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.amjopharm.2007.05.004_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","article-title":"Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research","volume":"42","author":"DiMatteo","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/eye.1998.56","article-title":"Compliance with timolol treatment in glaucoma","volume":"12","author":"Rotchford","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib21","first-page":"233","article-title":"Compliance in patients prescribed eyedrops for glaucoma","volume":"26","author":"Patel","year":"1995","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2105\/AJPH.83.5.711","article-title":"Treatment for glaucoma: Adherence by the elderly","volume":"83","author":"Gurwitz","year":"1993","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ophtha.2004.12.026","article-title":"Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?","volume":"112","author":"Robin","year":"2005","journal-title":"Ophthalmology"},{"issue":"Suppl 10","key":"10.1016\/j.amjopharm.2007.05.004_bib24","first-page":"S271","article-title":"Discontinuation rates of topical glaucoma medications in a managed care population","volume":"8","author":"Shaya","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib25","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","article-title":"Persistence and adherence with topical glaucoma therapy","volume":"140","author":"Nordstrom","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib26","first-page":"145","article-title":"Predictive power of a risk-assessment questionnaire across different disease states: Results in an elderly managed care enrolled population","volume":"7","author":"Balkrishnan","year":"2001","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00005650-199909000-00002","article-title":"Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy","volume":"37","author":"Choo","year":"1999","journal-title":"Med Care"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00005650-198808000-00007","article-title":"A general method of compliance assessment using centralized pharmacy records. Description and validation","volume":"26","author":"Steiner","year":"1988","journal-title":"Med Care"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib29","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1016\/S0149-2918(03)80347-8","article-title":"Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study","volume":"25","author":"Balkrishnan","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib31","first-page":"801","article-title":"Estimation with correctly interpreted dummy variables in semilogarithmic equations","volume":"71","author":"Kennedy","year":"1981","journal-title":"Am Econ Rev"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0167-6296(01)00086-8","article-title":"Estimating log models: To transform or not to transform?","volume":"20","author":"Manning","year":"2001","journal-title":"J Health Econ"},{"issue":"Suppl 1","key":"10.1016\/j.amjopharm.2007.05.004_bib33","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.ajo.2003.10.034","article-title":"Persistency with latanoprost or timolol in primary open-angle glaucoma suspects","volume":"137","author":"Schwartz","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib34","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0149-2918(03)80074-7","article-title":"Patient persistency with ocular prostaglandin therapy: A population-based, retrospective study","volume":"25","author":"Reardon","year":"2003","journal-title":"Clin Ther"},{"issue":"Suppl 1","key":"10.1016\/j.amjopharm.2007.05.004_bib35","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ajo.2005.09.011","article-title":"Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data","volume":"141","author":"Wilensky","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib36","series-title":"Presented at: Annual Meeting of American Academy of Ophthalmology","article-title":"Compliance and costs associated with latanoprost therapy. Introduction in a managed care setting","author":"Balkrishnan","year":"2000"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1543-5946(03)90003-1","article-title":"Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a Medicare health maintenance organization","volume":"1","author":"Balkrishnan","year":"2003","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.amjopharm.2007.05.004_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1081\/JAS-100000026","article-title":"A comparison of medication adherence indices to assess long-term inhaled corticosteroid medication use","volume":"38","author":"Balkrishnan","year":"2001","journal-title":"J Asthma"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594607000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594607000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T13:33:37Z","timestamp":1556804017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594607000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1543594607000232"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2007.05.004","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}